United Therapeutics (UTHR), in Collaboration with XVIVO Perfusion, Inc., Reports FDA Approval Of XPS and Steen Solution

April 29, 2019 6:10 AM

United Therapeutics Corporation (NASDAQ: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (XVIVO) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found